September 20, 2010

MERCK & CO: Pursuing Patent Violation Suits Over Filing of ANDAs

COMPANIES: Merck & Co Inc
Subscribe

Merck & Co. Inc. continues to pursue patent infringement suits in federal court against companies filing ANDA’s for generic montelukast (Singulair), aprepitant (Emend) and caspofungin (Cancidas). AstraZeneca and the Company…

TO CONTINUE READING,LOGIN or
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: New Jersey | United States